Study of 0417 Ointment in the Treatment of Atopic Dermatitis

• Status: Completed
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis.

Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a day, approximately 12 hours apart, for approximately 4 weeks.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fougera Pharmaceuticals Inc.
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Clinical diagnosis of Atopic Dermatitis

• Good health with the exception of Atopic Dermatitis

• Percent Body Surface Area minimum requirements

Exclusion Criteria:

• Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period.

• Subjects who have any systemic or dermatological disorders with the exception of Atopic Dermatitis